{"id":"https://openalex.org/W181725804","doi":"https://doi.org/10.1016/b978-0-08-025488-3.50031-3","title":"TOLERANCE, CROSS-TOLERANCE AND DEPENDENCE TO \u03bc AND K AGONISTS IN VIVO AND IN VITRO","display_name":"TOLERANCE, CROSS-TOLERANCE AND DEPENDENCE TO \u03bc AND K AGONISTS IN VIVO AND IN VITRO","publication_year":1980,"publication_date":"1980-01-01","ids":{"openalex":"https://openalex.org/W181725804","doi":"https://doi.org/10.1016/b978-0-08-025488-3.50031-3","mag":"181725804"},"language":"en","primary_location":{"id":"doi:10.1016/b978-0-08-025488-3.50031-3","doi":"https://doi.org/10.1016/b978-0-08-025488-3.50031-3","is_oa":false,"landing_page_url":"https://doi.org/10.1016/b978-0-08-025488-3.50031-3","pdf_url":null,"source":{"id":"https://openalex.org/S4306463230","display_name":"Elsevier eBooks","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"ebook platform"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Endogenous and Exogenous Opiate Agonists and Antagonists","raw_type":"book-chapter"},"volume":{"id":"https://openalex.org/W4256680644","display_name":"Endogenous and Exogenous Opiate Agonists and Antagonists"},"type":"book-chapter","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5083100447","display_name":"Susan J. Ward","orcid":"https://orcid.org/0000-0002-5729-5263","observed_orcids":["https://orcid.org/0000-0002-5729-5263"]},"institutions":[{"id":"https://openalex.org/I28407311","display_name":"University of Manchester","ror":"https://ror.org/027m9bs27","country_code":"GB","type":"education","lineage":["https://openalex.org/I28407311"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Susan J. Ward","raw_affiliation_strings":["Department of Pharmacology, University of Manchester, U.K., and Reckitt S Colman, Dansom Lane, Kingston upon Hull, U.K"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology, University of Manchester, U.K., and Reckitt S Colman, Dansom Lane, Kingston upon Hull, U.K","institution_ids":["https://openalex.org/I28407311"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102075470","display_name":"Colin F. C. Smith","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I28407311","display_name":"University of Manchester","ror":"https://ror.org/027m9bs27","country_code":"GB","type":"education","lineage":["https://openalex.org/I28407311"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Colin F.C. Smith","raw_affiliation_strings":["Department of Pharmacology, University of Manchester, U.K., and Reckitt S Colman, Dansom Lane, Kingston upon Hull, U.K"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology, University of Manchester, U.K., and Reckitt S Colman, Dansom Lane, Kingston upon Hull, U.K","institution_ids":["https://openalex.org/I28407311"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113565734","display_name":"Geoffrey Metcalf","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I28407311","display_name":"University of Manchester","ror":"https://ror.org/027m9bs27","country_code":"GB","type":"education","lineage":["https://openalex.org/I28407311"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Geoffrey Metcalf","raw_affiliation_strings":["Department of Pharmacology, University of Manchester, U.K., and Reckitt S Colman, Dansom Lane, Kingston upon Hull, U.K"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology, University of Manchester, U.K., and Reckitt S Colman, Dansom Lane, Kingston upon Hull, U.K","institution_ids":["https://openalex.org/I28407311"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5113438283","display_name":"John M.H. Rees","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I28407311","display_name":"University of Manchester","ror":"https://ror.org/027m9bs27","country_code":"GB","type":"education","lineage":["https://openalex.org/I28407311"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"John M.H. Rees","raw_affiliation_strings":["Department of Pharmacology, University of Manchester, U.K., and Reckitt S Colman, Dansom Lane, Kingston upon Hull, U.K"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology, University of Manchester, U.K., and Reckitt S Colman, Dansom Lane, Kingston upon Hull, U.K","institution_ids":["https://openalex.org/I28407311"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I28407311"],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":"103","last_page":"106"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10814","display_name":"Neuropeptides and Animal Physiology","score":0.9804999828338623,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10814","display_name":"Neuropeptides and Animal Physiology","score":0.9804999828338623,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11178","display_name":"Receptor Mechanisms and Signaling","score":0.010400000028312206,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.0019000000320374966,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/opioid-tolerance","display_name":"opioid tolerance","score":0.7570000290870667},{"id":"https://openalex.org/keywords/cross-tolerance","display_name":"cross-tolerance","score":0.996999979019165},{"id":"https://openalex.org/keywords/opioid-use-disorder","display_name":"opioid use disorder","score":0.7979999780654907},{"id":"https://openalex.org/keywords/mu-opioid-receptor-agonists","display_name":"mu-opioid receptor agonists","score":0.7910000085830688},{"id":"https://openalex.org/keywords/kappa-opioid-receptor-agonists","display_name":"kappa opioid receptor agonists","score":0.9769999980926514},{"id":"https://openalex.org/keywords/morphine","display_name":"morphine","score":0.9860000014305115},{"id":"https://openalex.org/keywords/ethylketocyclazocine","display_name":"ethylketocyclazocine","score":0.9660000205039978},{"id":"https://openalex.org/keywords/opioid-receptors","display_name":"opioid receptors","score":0.4620000123977661},{"id":"https://openalex.org/keywords/ileum","display_name":"ileum","score":0.6570000052452087}],"concepts":[{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.7783076763153076},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.7698105573654175},{"id":"https://openalex.org/C2777389121","wikidata":"https://www.wikidata.org/wiki/Q81225","display_name":"Morphine","level":2,"score":0.7245944142341614},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.660738468170166},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.5066150426864624},{"id":"https://openalex.org/C2776885963","wikidata":"https://www.wikidata.org/wiki/Q245204","display_name":"Antagonist","level":3,"score":0.49803805351257324},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.49130478501319885},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.4689461886882782},{"id":"https://openalex.org/C946728","wikidata":"https://www.wikidata.org/wiki/Q746408","display_name":"Cross-tolerance","level":3,"score":0.42291539907455444},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.24311316013336182},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.07664337754249573},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1016/b978-0-08-025488-3.50031-3","doi":"https://doi.org/10.1016/b978-0-08-025488-3.50031-3","is_oa":false,"landing_page_url":"https://doi.org/10.1016/b978-0-08-025488-3.50031-3","pdf_url":null,"source":{"id":"https://openalex.org/S4306463230","display_name":"Elsevier eBooks","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"ebook platform"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Endogenous and Exogenous Opiate Agonists and Antagonists","raw_type":"book-chapter"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.5683000087738037,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":5,"referenced_works":["https://openalex.org/W1900414416","https://openalex.org/W2000282652","https://openalex.org/W2039409606","https://openalex.org/W2058918147","https://openalex.org/W2256287030"],"related_works":["https://openalex.org/W2074405093","https://openalex.org/W2062119024","https://openalex.org/W2259973577","https://openalex.org/W2030064013","https://openalex.org/W2225539690","https://openalex.org/W2045960840","https://openalex.org/W2091338914","https://openalex.org/W1891806829","https://openalex.org/W1998436816","https://openalex.org/W7096894357"],"abstract_inverted_index":null,"counts_by_year":[],"updated_date":"2026-10-17T09:40:24.721904","created_date":"2016-06-24T00:00:00"}